[EN] HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER<br/>[FR] INHIBITEURS HÉTÉROBICYCLIQUES DE MAT2A ET LEURS MÉTHODES D'UTILISATION POUR LE TRAITEMENT DU CANCER
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2019191470A1
公开(公告)日:2019-10-03
The present disclosure provides for compounds according to Formula I or Formula II and their pharmaceutically acceptable salts, stereoisomers, and/or tautomers thereof,.Also provided are pharmaceutical compositions and the compounds of formulae I and II for use in methods of treating cancers via inhibition of MAT2B, including some cancers in which the gene encoding methylthioadenosine phosphorylase (MTAP) is deleted.